Clinical Trials on Thyroid Cancer, Follicular in Taiwan

Total 1755 results

National Taiwan University Hospital

Recruiting

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer

Thyroid Cancer | Papillary Thyroid Cancer | Follicular Thyroid Cancer

Taiwan
National Taiwan University Hospital

Recruiting

Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer

Thyroid Cancer | Follicular Thyroid Cancer

Taiwan
National Health Research Institutes, Taiwan

Recruiting

A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients (TOPICS-THYROID)

Thyroid Cancer

Taiwan
National Taiwan University Hospital

Recruiting

Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients

Differentiated Thyroid Cancer

Taiwan
Chang Gung Memorial Hospital

Completed

Circulating Biomarkers to Identify Thyroid Cancer

Thyroid Cancer, Papillary | Thyroid Cancer | Benign Thyroid Tumor

Taiwan
Far Eastern Memorial Hospital

Unknown

An Easy Sonographic Scoring System for Predicting Malignant Thyroid Nodules

Thyroid Cancer

Taiwan
National Taiwan University Hospital

Recruiting

Prospective Comparison of the Effect on Antiadhesive Barriers During Thyroid or Parathyroid Surgery

Goiter | Thyroid Cancer | Thyroidectomy

Taiwan
Taichung Veterans General Hospital

Recruiting

Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment

Thyroid Cancer

Taiwan
China Medical University Hospital

Completed

Clinical Prediction Thyroid Cancer With Thyroid Ultrasonography

Thyroid Cancer

Taiwan
National Taiwan University Hospital

Completed

Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3

Thyroid Cancer

Taiwan
Fudan University
Shanxi Province Cancer Hospital; Inner Mongolia Cancer Hospital Affiliated...

Recruiting

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Advanced Thyroid Cancer Patients Who Received Target Therapy

China
Novartis Pharmaceuticals

Active, not recruiting

Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer

Differentiated Thyroid Cancer

China, Canada, Taiwan, India, Korea, Republic of, Turkey, Malaysia, Vietnam, Brazil, United States, Argentina
Kaohsiung Medical University Chung-Ho Memorial...
Kaohsiung Medical University

Completed

Neuromuscular Block Monitoring During Monitored Thyroidectomy

Thyroid Surgery

Taiwan
Kaohsiung Medical University Chung-Ho Memorial...

Completed

The Improvement of Intraoperative Neuromonitoring of Recurrent Laryngeal Nerve

Thyroid Intra-Operative Injury

Taiwan
Kaohsiung Medical University Chung-Ho Memorial...

Completed

The Optimal Dosage of Rocuronium for Intraoperative Neuromonitoring During Thyroid Surgery (IONM)

THYROIDECTOMY

Taiwan
Chang Gung Memorial Hospital

Completed

2-day Prophylactic Antibiotic is Effective in Transoral Endoscopic Thyroidectomy

Thyroid Nodule

Taiwan
Eisai Co., Ltd.

Completed

A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China

Differentiated Thyroid Cancer (DTC)

China
Chang Gung Memorial Hospital

Recruiting

The Prevalence and Risk Factors for Thyroid Dysfunction in Pregnant Women in Taiwan

Thyroid Disease Pregnancy

Taiwan
National Taiwan University Hospital

Completed

Levothyroxine Treatment in Thyroid Benign Nodular Goiter

Thyroid Nodule

Taiwan
Fu Jen Catholic University

Not yet recruiting

3D Thyroid Education Model for Student

Satisfaction, Personal

Taiwan
Fu Jen Catholic University

Not yet recruiting

Three-dimensional Thyroid Education Model

Satisfaction, Patient

Taiwan
Pell Bio-Med Technology Co., Ltd.

Recruiting

Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma

Diffuse Large B Cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Large B-cell Lymphoma | Follicular Lymphoma Grade 3B | Follicular Lymphoma Grade 3A

Taiwan
National Taiwan University Hospital

Recruiting

Thyroid Disease Diagnosis by Mutiple Ultrasonic Factors.

Diagnoses Disease | Thyroid | Nodule

Taiwan
Pell Bio-Med Technology Co., Ltd.

Recruiting

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

Diffuse Large B Cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Large B-cell Lymphoma | Follicular Lymphoma Grade 3B | Follicular Lymphoma Grade 3A

Taiwan
Taichung Veterans General Hospital

Recruiting

The Association Between Autoimmune or Inflammation and Thyroid Disease

THYROTOXICOSIS

Taiwan
Kaohsiung Medical University Chung-Ho Memorial...

Unknown

Intraoperative Electromyographic Monitoring of the Recurrent Laryngeal Nerve in Thyroid Surgery

Thyroid Surgery | Recurrent Laryngeal Nerve | Electromyographic Monitoring

Taiwan
National Cheng-Kung University Hospital

Completed

Sigmoid Colon Organ Motion in Radiotherapy

Sigmoid Colon Cancer | Sigmoid Cancer

Taiwan
TaiRx, Inc.

Completed

Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients

Carcinoma | Advanced Cancer

Taiwan
Rise Biopharmaceuticals, Inc.
T-TOP Clinical Research Co., Ltd.

Recruiting

RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer

Pancreatic Cancer | Pancreatic Cancer Metastatic | Pancreatic Cancer Non-resectable

Taiwan
National Taiwan University Hospital

Completed

Early Detection of Autoimmune Thyroid Heart Disease Via Urinary Exosomal Proteins

Heart Failure | Thyroid Diseases

Taiwan
Standard Chem. & Pharm. Co., Ltd.

Terminated

Safety, Tolerability and Pharmacokinetics of DCBCI0901 in Patients With Advanced Solid Tumor

Cancer

Taiwan
National Health Research Institutes, Taiwan
National Cheng-Kung University Hospital

Recruiting

Genomics and Prognosis in GI Cancers

Liver Cancer | GI Cancer

Taiwan
National Taiwan University Hospital

Recruiting

Diagnostic and Prognostic Significance of Computerized Cytologic Morphometry of the Thyroid Neoplasm

Computerized Cytomorphometry

Taiwan
Exelixis
Ipsen

Active, not recruiting

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

Differentiated Thyroid Cancer

Hong Kong, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Croatia, Czechia, France, Germany, Hungary, Israel, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Russian Federation, Spain, Taiwan, ... and more
National Taiwan University Hospital

Completed

Prognostic Significance of Fine-Needle Aspiration Cytology Features in Papillary Thyroid Carcinoma

Thyroid Neoplasms

Taiwan
TaiRx, Inc.

Completed

Safety and Pharmacokinetic Study of CVM-1118 Extended-Release in Advanced Cancer Patients

Advanced Cancer

Taiwan
National Cheng-Kung University Hospital
National Cheng Kung University

Recruiting

Physical Training for Elderly Cancer Patients With Cachexia (TEECH-01)

Cancer | Cancer Cachexia | Geriatric Assessment

Taiwan
National Cheng-Kung University Hospital

Unknown

Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal Cancer (UFUR)

Colon Cancer

Taiwan
PharmaEngine

Completed

Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy

Metastatic Colorectal Cancer

Taiwan
National Cheng-Kung University Hospital

Terminated

Metformin in Stage IV Lung Adenocarcinoma

Non-small Cell Lung Cancer

Taiwan
Polaris Group

Terminated

Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers

Advanced Solid Cancers

Taiwan
National Cheng-Kung University Hospital
Kaohsiung Medical University; Kaohsiung Veterans General Hospital.; Chi Mei Medical...

Recruiting

Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer

Endometrial Cancer Recurrent

Taiwan
National Cheng-Kung University Hospital

Unknown

The Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver Metastases (CBL)

Colorectal Cancer

Taiwan
National Health Research Institutes, Taiwan
China Medical University Hospital; Taipei Veterans General Hospital, Taiwan; National... and other collaborators

Completed

Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy

Head & Neck Cancer

Taiwan
National Taiwan University Hospital

Completed

Selumetinib in Combination With Gefitinib in NSCLC Patients

Non-small Cell Lung Cancer (NSCLC)

Taiwan
National Cheng-Kung University Hospital

Unknown

Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer

Non-Small Cell Lung Cancer

Taiwan
National Cheng Kung University

Completed

Assessments on Current Pain Managements in Upper Gastrointestinal Cancer Patients

Depression | Quality of Life | Pain | Neuropathic Pain | Upper GI Cancer

Taiwan
Pfizer

Completed

Clinical Outcome Of Hormonal Receptor Positive, Her-2 Negative Breast Cancer In Taiwan

ER/PR(+), Her2(-) Breast Cancer

Taiwan
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Daiichi Sankyo, Inc.

Completed

Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer

Recurrent Thyroid Cancer | Anaplastic Thyroid Cancer

United States
National Taiwan University Hospital

Completed

AUY922 in Patient With Stage IV NSCLC (NSCLC)

Non-small Cell Lung Cancer (NSCLC)

Taiwan

Clinical Trials on Thyroid Cancer, Follicular in Taiwan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations